Evolution of systemic therapy from 2015 to 2019 for older patients in the United States with metastatic renal cell carcinoma.

被引：0
|
作者：
Chow, Ryan Dz-Wei
Long, Jessica B.
Hassan, Sirad
Wheeler, Stephanie B.
Spees, Lisa
Leapman, Michael
Hurwitz, Michael E.
McManus, Hannah Dzimitrowicz
Gross, Cary Philip
Dinan, Michaela Ann
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[3] Yale Sch Med, Dept Urol, New Haven, CT USA
[4] Duke Canc Ctr, Durham, NC USA
[5] Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
610
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
    Yan, Xieqiao
    Li, Siming
    Chi, Zhihong
    Si, Lu
    Cui, Chuanliang
    Kong, Yan
    Zhou, Li
    Tang, Bixia
    Wu, Xiaowen
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Bai, Xue
    Dai, Jie
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] Patient priorities and expectations of systemic therapy in metastatic renal cell carcinoma.
    Battle, Dena
    Vaishampayan, Ulka N.
    Msaouel, Pavlos
    Pal, Sumanta Kumar
    Zhang, Tian
    Staehler, Michael D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Systemic therapy of metastatic renal cell carcinoma. From many options to the therapeutic strategy
    Ringhoffer, M.
    Rinnab, L.
    Kuefer, R.
    Greiner, J.
    UROLOGE, 2009, 48 (11): : 1308 - 1317
  • [4] Ablative therapy to induce local and systemic immune changes in patients with metastatic renal cell carcinoma.
    Campbell, Matthew T.
    Matin, Surena F.
    Slack, Rebecca
    Sun, Jing Jing
    Tang, Derek Ng
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
    Mittal, Abhenil
    Al-Ezzi, Esmail Mutahar
    Li, Xuan
    Wilson, Brooke
    Spiliopoulou, Pavlina
    Sridhar, Srikala S.
    Fallah-Rad, Nazanin
    Chung, Peter W. M.
    Hamilton, Robert James
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [6] Clinical utility of biomarkers of systemic inflammation for patients with metastatic renal cell carcinoma.
    Harris, Wayne
    Akbashev, Mikhail Y.
    Kucuk, Omer
    Liu, Yuan
    Hsiao, Wayland
    Osunkoya, Adeboya O.
    Baumgarten, Deborah O.
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Systemic therapy for elderly patients with metastatic renal cell carcinoma
    Miura, Yuji
    ANNALS OF ONCOLOGY, 2019, 30 : 48 - 48
  • [8] Deferred Systemic Therapy in Patients With Metastatic Renal Cell Carcinoma
    Mitchell, Aaron P.
    Hirsch, Bradford R.
    Harrison, Michael R.
    Abernethy, Amy P.
    George, Daniel J.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : E159 - E166
  • [9] Neutrophil extracellular traps in relation to efficacy of systemic therapy for metastatic renal cell carcinoma.
    Shang, Bing-Qing
    Shi, Hongzhe
    Bi, Xin-Gang
    Song, Yan
    Qu, Wang
    Bai, Hongsong
    Wu, Jie
    Cui, Honglei
    Du, Gan
    Guo, Lei
    Zheng, Shan
    Ying, Jianming
    Li, Changling
    Ma, Jianhui
    Zhou, Ai-Ping
    Zhang, Shudong
    Shou, Jianzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [10] Trends of Systemic Therapy Use for Renal Cell Carcinoma in the United States
    Ferry, Elizabeth K.
    Minnillo, Brian J.
    Maurice, Matthew J.
    Abouassaly, Robert
    Zhu, Hui
    UROLOGY, 2015, 85 (06) : 1399 - 1403
12345